Hostname: page-component-6898cfcb55-cbk24 Total loading time: 0 Render date: 2026-11-11T20:36:54.938Z Has data issue: false hasContentIssue false

Biochemical composition and metabolic pathways of filarial worms Setaria cervi: search for new antifilarial agents

Published online by Cambridge University Press:  01 September 2007

Rumana Ahmad
Affiliation:
Division of Biochemistry, Po Box 173, Central Drug Research Institute, Chattar Manzil Palace, Lucknow-226001, India
Arvind K. Srivastava*
Affiliation:
Division of Biochemistry, Po Box 173, Central Drug Research Institute, Chattar Manzil Palace, Lucknow-226001, India
*
*Fax: +91-522-2623938 E-mail: drarv1955@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

The main problem regarding the chemotherapy of filariasis is that no safe and effective drug is available yet to combat the adult human filarial worms. Setaria cervi, the causal organism of setariasis and lumbar paralysis in cattle, is routinely employed as a model organism for conducting biochemical and enzymatic studies on filarial parasites. In view of the practical difficulties in procuring human strains of Wuchereria bancrofti and Brugia malayi for drug screening, the bovine filarial parasite S. cervi, resembling the human species in having microfilarial periodicity and chemotherapeutic response to known antifilarial agents, is widely used as a model in such studies. For a rational approach to antifilarial chemotherapy, knowledge of the biochemical composition and metabolic pathways of this helminth parasite may be of paramount importance, so that more potent antifilarial agents based on specific drug targets can be identified in drug discovery programmes. The present review provides an update on the biochemistry of the important metabolic pathways functioning within this potentially important bovine parasite, that have so far been studied, and on those that need to be investigated further so as to identify novel drug targets that can be exploited for designing new antifilarial drugs.

Information

Type
Review Article
Copyright
Copyright © Cambridge University Press 2007
Figure 0

Fig. 1Generalized life cycle of filarial worms.

Figure 1

Table 1Lipid fractions isolated from S. cervia; reproduced according to Ansari et al. (1973).

Figure 2

Table 2Properties of individual phospholipids in S. cervia; reproduced and modified according to Ansari et al. (1973).

Figure 3

Fig. 2Proposed catabolic pathway of carbohydrates in S. digitata. → , ↔  Pathways studied; ––– pathways not established; see Banu et al. (1991). ADP, Adenosine diphosphate; ATP, adenosine triphosphate; FP, flavoprotein; FPH2, reduced flavoprotein; FR, fumarate reductase; LDH, lactate dehydrogenase; MDH, malate dehydrogenase; ME, malic enzyme; NAD+, nicotinamide adenine dinucleotide; NADH, reduced nicotinamide adenine dinucleotide; NAD(P)+, nicotinamide adenine dinucleotide phosphate; NAD(P)H, reduced nicotinamide adenine dinucleotide phosphate; OA, oxaloacetate; PEP, phosphoenolpyruvate; PEPCK, phosphoenolpyruvate carboxykinase; Pi, inorganic phosphorus; PK, pyruvate kinase; SDH, succinate dehydrogenase.

Figure 4

Table 3Distribution of the enzymes of S. cervi in different subcellular fractionsa; reproduced according to Hussain et al. (1990).

Figure 5

Table 4Specific activitiesa of the enzymes of the TCA cycle in cell-free extracts of S. cervi; reproduced and modified according to Agarwal et al. (1986).

Figure 6

Table 5Activities of enzymes in the soluble and particulate fractions of S. digitata (nmol substrate or co-factor min−1 mg−1 protein); reproduced according to Banu et al. (1991).

Figure 7

Table 6Activities of fumarate reductase, succinate dehydrogenase, SDH–Q reductase and succinate oxidase in mitochondria-like particles of S. digitata; reproduced according to Unnikrishnan & Raj (2000).